This site is intended for health professionals only

Pharminox to design and build second set of isolators for France



The directors of Pharminox Isolation Ltd are very pleased to announce that a repeat order for two isolators for a Pharmaceutical plant in France has been received, designed, delivered and installed.
A pair of Pharminox isolators were installed and validated at the client site in mid France, by Rick Benson and Tim Coles, in October last year. A similar set of isolators were ordered mid 2013 with a delivery date set in Q4 2013. The new isolators were designed by Tim Coles and included additional features, which were well received by the client. This time the construction comprised of clear acrylic bodies with stainless steel base trays.
The original isolators were also designed by Tim Coles and were built by Pharminox Isolation to the client’s requirements. The construction comprised of clear acrylic bodies and Trespa base trays. The isolators are linked together by a common passbox also in clear acrylic. Additional safety features were proposed by Pharminox were approved by the client and these were incorporated in the new isolator design.
Tim Coles, managing director of Pharminox Isolation said “In this particular application, the client required an entirely manual operation with user-set air flow rate and isolator pressure (either positive or negative). This was achieved with potentiometer adjustable fans on both inlet and exhaust of the turbulent flow ventilation systems. We were pleased to be asked to provide two more isolators and include some additional features too. Our client is a delight to work with and the installation and validation all went smoothly to plan”.
Additional features of the new isolators included five access doors with pneumatic seals that interlock to prevent more than one door opening at a time. A dual-level hydrogen peroxide meter was fitted to monitor the concentration of hydrogen peroxide at both high and low level in the isolators and passbox. Bio-decontamination is achieved through one of two options that the client currently has on site and uses regularly.

Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine